ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.022,04
-0,27%
US Dollar vs BRL
5,1958
0,01%
Bitcoin
57.088,19
-5,80%
Brent Oil
84,06
-2,14%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Oncorus Inc (ONCR)

  7. Oncorus Inc (ONCR) Notícias

ONCR

Oncorus (ONCR)

Oncorus Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONCR
DataHoraFonteTítuloCódigoCompanhia
07/08/202307:52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
03/08/202318:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ONCROncorus Inc
03/08/202317:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCROncorus Inc
26/06/202317:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
23/06/202307:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONCROncorus Inc
16/06/202310:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCROncorus Inc
12/06/202307:45Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ONCROncorus Inc
01/06/202317:05GlobeNewswire Inc.Oncorus Announces Workforce Reduction PlanNASDAQ:ONCROncorus Inc
22/05/202317:05GlobeNewswire Inc.Oncorus Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
16/05/202317:38Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ONCROncorus Inc
01/05/202308:36Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ONCROncorus Inc
24/03/202317:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONCROncorus Inc
24/03/202308:00GlobeNewswire Inc.Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
14/02/202310:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
04/01/202309:00GlobeNewswire Inc.Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug CandidatesNASDAQ:ONCROncorus Inc
27/12/202220:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
22/12/202208:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ONCROncorus Inc
30/11/202209:00GlobeNewswire Inc.Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with CancerNASDAQ:ONCROncorus Inc
23/11/202210:00GlobeNewswire Inc.Oncorus to Participate in Upcoming Investor ConferencesNASDAQ:ONCROncorus Inc
18/11/202210:00GlobeNewswire Inc.Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual MeetingNASDAQ:ONCROncorus Inc
07/11/202208:15TipRanksOncorus (ONCR) Gets a Buy from H.C. WainwrightNASDAQ:ONCROncorus Inc
02/11/202217:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONCROncorus Inc
02/11/202208:00GlobeNewswire Inc.Oncorus Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
01/11/202217:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCROncorus Inc
07/10/202210:00GlobeNewswire Inc.Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of CancerNASDAQ:ONCROncorus Inc
26/09/202208:00GlobeNewswire Inc.Oncorus to Present at Chardan’s 6th Annual Genetic Medicines ConferenceNASDAQ:ONCROncorus Inc
06/09/202208:00GlobeNewswire Inc.Oncorus to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:ONCROncorus Inc
15/08/202207:15TipRanksH.C. Wainwright Sticks to Its Buy Rating for Oncorus (ONCR)NASDAQ:ONCROncorus Inc
04/08/202208:00GlobeNewswire Inc.Oncorus Reports Second Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
23/06/202208:00GlobeNewswire Inc.Oncorus Appoints Douglas Fambrough to Board of DirectorsNASDAQ:ONCROncorus Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONCR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
AZEV4
AZEVEDO PN
BOV
BLAU3
Blau Farmaceutica ON
BOV
TECN3
TECHNOS ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados